This Guy Used Reddit to Build a Crowdsourced Stock Portfolio. The Results Were Actually Not Bad ... Kind Of

Late last year, Reddit user PhantomPumpkin began building a simulated portfolio. Over a three-week period, he invested $10,000 in play money into any stock talked about positively on the subreddit r/investing. 

Is this a viable portfolio building strategy for the long term? Absolutely not. But it is incredibly interesting. In the anonymous, Wild West world that is Reddit, how would the communal Internet fare against the efficiency of the global stock market?

To find out, I updated his portfolio with current prices as of today, one year later.

Let's get right to it. How'd he do?
Over that three-week period, 30 individual stocks were virtually purchased. Each investment represented $10,000 in play money. Because of what I can only determine to be rounding errors, the total investment ended up totaling $288,713.54.

Today, the portfolio is worth $404,015.97. That's a 39.9% return in roughly one year. Not bad at all.

But it's not enough to just accept this near 40% return without benchmarking it against alternative parking spots for your money. Forty percent sounds great, unless you could have returned 60% somewhere else.

Compared with the S&P 500 and the Dow Jones Industrial Average, this portfolio performed quite well. The S&P is up 27% over the past year, and the Dow is up 23%. The Russell 2000 though is up 35%. The Reddit portfolio still wins, but only slightly.

Taking a deeper dive
Overall, the portfolio saw 10 stocks lose money, while 29 made money, and one was a push. 

Of the 30 investments, seven returned greater than 100%! Leading the way was Acadia Pharmaceuticals  (NASDAQ: ACAD  ) , returning 359%, followed by MannKind, returning 136% and AcelRX Pharmaceuticals  (NASDAQ: ACRX  ) returning 122%.

Only one investment lost more than 50% of its value: OXiGENE, which lost 52%.

Notice a pattern emerging? Redditors, for whatever reason, seem to really like pharmaceutical and biotech companies. Other big winners -- Pitney Bowes (NYSE: PBI  ) , Seagate Technologies, and First Solar (NASDAQ: FSLR  ) -- while not drug or bio companies, are high-risk, high-reward companies that bet on the future of technology.

To see the portfolio, I've uploaded the spreadsheet for viewing here.

A better approach
With only 30 stocks in this portfolio, and with such a heavy weighting toward technology, biology, and pharmaceuticals, is 39.9% really a good return? My instinct tells me no.

In my judgment, this risk profile here far exceeds that of the Russell 2000, and absolutely the S&P or Dow Jones Industrials. And it far exceeds what the risk profile for most investors should be as well!

So should you begin checking r/investing everyday for the next big investment opportunity? Absolutely not!

The key to investing is doing your own homework, understanding what companies actually do, what makes them successful today and tomorrow, and then investing for the very long term. 

Don't put your nest egg, your future, your children's future, at such undue risk based on advice of the anonymous masses.

In the game of investing, slow and steady wins the race. A Reddit-driven portfolio is a shortcut you should avoid.

The top stock to buy in 2014 and own forever
There's a huge difference between a good stock, and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Have a comment or question about real estate, banks, or financial stocks? Like Jay on Facebook and leave your question or comment!

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On December 22, 2013, at 4:12 PM, prginww wrote:

    I've done something similar but not with real money. I open a Motley Fool CAPS account and choose to use the Fool community to see how well crowd sourcing would work. I started with 5 star stocks and picked the 200 with the most active picks. It will be 1 year on April 30th. Currently the account has an accuracy of 47.5%, a score of 258.58, and an average pick score of 1.29%. The player rating is 53.76 as of today.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2773496, ~/Articles/ArticleHandler.aspx, 9/27/2016 10:10:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,128.25 33.42 0.18%
S&P 500 2,153.12 7.02 0.33%
NASD 5,277.59 20.10 0.38%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 9:55 AM
ACAD $34.86 Up +0.56 +1.62%
ACADIA Pharmaceuti… CAPS Rating: **
ACRX $3.73 Up +0.11 +3.04%
AcelRx Pharmaceuti… CAPS Rating: ***
FSLR $38.24 Up +0.99 +2.66%
First Solar CAPS Rating: ***
PBI $17.69 Up +0.09 +0.51%
Pitney Bowes CAPS Rating: **